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Abstract 
This contribution reports the design, synthesis and photochemical properties of a novel cationic, water 
soluble, β-cyclodextrin (βCD) conjugate integrating an anthracene moiety and a nitroaniline derivative 
within the primary side of the βCD scaffold. Photoinduced energy transfer between the anthracene and 
the nitroaniline chromophores effectively suppresses the fluorescence of the anthracene unit. Excitation 
with visible light triggers the release of nitric oxide (NO) from the nitroaniline chromophore, 
accompanied to the concomitant revival of the anthracene fluorescence, which acts as an optical 
reporter for detecting the amount of the NO released. Furthermore, the anthracene moiety 
photogenerates singlet oxygen (1O2) sequentially to NO release. The conjugate is also able to 
accommodate hydrophobic guests within the βCD cavity, as proven by using naphthalene as a model 
compound. In view of the key role NO and 1O2 play as anticancer and antibacterial species, the present 
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βCD derivative represents an intriguing candidate for further studies in biopharmaceutical research 
addressed to multimodal therapeutic applications. 
Keywords: Cyclodextrin, nitric oxide, singlet oxygen, light, fluorescence, 
 
1. Introduction 
 
Cyclodextrins (CDs) have been greatly developed during the last thirty years as carriers of 
“conventional” drugs (Davis and Brewster, 2004; Loftsson and Douchene, 2007). However, the use of 
CDs as suitable vehicles for photoactivable therapeutic compounds has been only recently object of 
attention (Mazzaglia et al., 2012).  Due to their hydrophobic cavity, natural CDs can host a variety of 
photosensitive agents by supramolecular interactions (Bortolus and Monti, 1996; Monti and Sortino, 
2002). Nevertheless, in most cases, the low binding constants between unmodified CDs and guest 
molecules represent a major drawback of these systems as bio-carriers, making the modification of the 
CD structure strictly necessary in view of actual applications (Mazzaglia et al., 2006). Modification of 
the CDs molecular scaffold through functionalization of the primary and/or secondary hydroxyl groups 
with suitable photoresponsive units allows to obtain multifunctional nanocarriers with intriguing 
properties whilst, at the same time, maintaining the macrocycle’s capacity for guests encapsulation 
(Mourtzis et al., 2008; Mourtzis et al., 2007; Yannakopoulou et al., 2011). 
Nitric oxide (NO) is a pleiotropic bioregulator of important physiological and pathophysiological 
processes encompassing neurotransmission, vasodilatation and hormone secretion in living bodies 
(Ignarro, 2010). Besides, NO is an excellent sacrificial antioxidant, anticancer and antibacterial agent 
(Ignarro, 2009). This scenario has open a fervent research activity devoted to developing compounds 
able to release NO under physiological conditions as potential pharmaceuticals to fight a variety of 
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diseases (Wang et al., 2005; Wang et al., 2002; Riccio and Schoenfisch, 2012; Seabra and Durán, 
2009). However, the biological effects of NO are strictly depending on its concentration, location and 
dose (Jia et al., 2002). This has made the light-activated NO donors very appealing due to the superb 
spatiotemporal accuracy the light triggering offers (Ford, 2008; Sortino, 2010; Fry and Mascharak, 
2011; Ford, 2013). Several NO photodonors (NOPD) have been supramolecularly combined with CDs 
derivatives (Fraix et al., 2016). In contrast, only limited examples of NO photodonor covalent 
conjugates with CDs are reported to date (Piras et al., 2013).  
Quantification of the NO delivery in real time is another important issue to be faced, especially when 
the main interest is to reach a critical molecule concentration to induce a specific effect. A suitable way 
to address this quantification task is based on the use of a fluorescent reporter. This elegant strategy 
relies on the simultaneous photorelease of the desired bioactive species, i.e. NO, and a fluorescent 
component (the reporter) from the same nonfluorescent precursor (Veldhuyzen et al., 2003; Pellois et 
al., 2004; Weinstain et al., 2010). The release process can be thus easily quantified by monitoring the 
fluorescence emission of the reporter, which acts exactly as an optical counter of the bioactive species. 
Recently, we have reported interesting properties of an ad-hoc designed molecular conjugate 
integrating two chromogenic centers within the same covalent skeleton (Vittorino et al., 2011; Kirejev 
et al., 2014), an anthracene moiety and a nitroaniline derivative, this latter as a suitable NOPD (28). In 
this compound, the typical emission of the anthracene fluorophore is completely suppressed by a 
photoinduced energy transfer to the nitroaniline moiety. We demonstrated that the photorelease of NO 
leads to the revival of the fluorescence of anthracene fluorophore which acts as a fluorescent reporter 
for the NO delivery in living cells (Vittorino et al., 2011; Kirejev et al., 2014).  
Based on the above scenario we considered it of value to translate this NO photorelease with 
fluorescent reporting concept in a novel conjugate, which covalently integrates the NO photoreleaser 
and the anthracene moiety within the same positively charged βCD scaffold. This contribution reports 
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the synthesis, characterization and photochemical properties of the cationic βCD conjugate AN-βCD-
NOPD and the suitable model compounds AN-βCD and βCD-NOPD (Fig. 1).   
NH
NH
NO2
F3C
NH
Fluorescent reporter
NO photodonor
NH
NH
NO
2
F3C
NH
AN-βCD-NOPD AN-βCD βCD-NOPD
 
Fig 1. Schematic of the multifunctional β-CD conjugate AN-βCD-NOPD and the model compounds 
AN-βCD and βCD-NOPD. 
 
2. Experimental section 
 
2.1. Chemicals 
6-Monodeoxy-6-monoazido-βCD and 6-monotosyl-βCD are fine chemical products of CycloLab, 1,3-
diaminopropanol (≥ 99%), 4-nitro-3-(trifluoromethyl)aniline (98%), glycidyltrimethylammonium 
chloride (technical grade, ≥ 90%), sodium azide (ReagentPlus®, ≥ 99.5%), hydrazine monohydrate 
(reagent grade, 98%), sodium borohydride (≥ 98.0%), anthracene-9-carboxaldehyde (≥ 97.0%), p-
toluenesulfonyl chloride (ReagentPlus®, ≥ 99%), trimethylamine (≥ 99%), 1,3-propanedithiol (≥ 99%), 
palladium on carbon (5%), were sourced from Sigma-Aldrich. 
Dimethyl sulfoxide, formic acid, methanol, pyridine were obtained from Molar Chemicals. 
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2.2. Instrumentation 
1H-, 13C- NMR spectra and DEPT-ed-HSQC spectra were recorded in DMSO-d6 or D2O (10 mg 
dissolved in 0.8 mL of deuterated solvent) on a Varian DDR-600 at 600 MHz spectrometer at 298 K. 
Mass spectra were obtained on Bruker ESQUIRE 3000 ES-ion trap instrument with electrospray 
ionization (ESI) in negative mode. All samples were dissolved in water. 
Preparative chromatographic separations were performed on a Büchi preparative chromatography 
system using SiliCycle Silica Cartridge (4 cm x 15 cm) packed with Lichroprep (120 g) RP-18 Phase 
(40-63 µm) as a stationary phase and water-methanol gradient elution. The chromatographic station 
was equipped with Büchi UV Photometer C-635 as a detector (detection wavelength set at 390 nm for 
NOPD appended derivatives and at 245 nm for the tosylated intermediate). 
UV-Vis absorption and fluorescence spectra were recorded with a Jasco V 650 spectrophotometer and 
a Fluorolog-2 (Model, F111) spectrofluorimeter, respectively. Fluorescence lifetimes were recorded 
with the same spectrofluorimeter equipped with a TCSPC Triple Illuminator. The samples were 
irradiated by a pulsed diode excitation source Nanoled at 370 nm. The kinetic was monitored at 420 nm 
and each solution itself was used to register the prompt at 370 nm. The system allowed measurement of 
fluorescence lifetimes from 200 ps. The multiexponential fit of the fluorescence decay was obtained 
using the following equations: I(t) = A1exp(-t/τ1) + A2exp(-t/τ2) (for the biexponential fit) and I(t) = 
A1exp(-t/τ1) + A2exp(-t/τ2) + A3exp(-t/τ3) (for the triexponential fit). Multiexponential fitting were used 
because they gave much better chi-square values than monoexponential fitting. 
1O2 emission was registered with the same spectrofluorimeter as above equipped with a NIR-sensitive 
liquid nitrogen cooled photomultiplier, exciting the air-equilibrated samples in D2O solution at 380 nm 
with the fluorimeter lamp. 
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Photolysis of the samples in solution was performed in a thermostated quartz cell (1 cm pathlength, 3 
mL capacity) under gentle stirring, by using a continuum laser with λexc = 405 nm (ca. 100 mW) having 
a beam diameter of ca. 1.5 mm.  
NO release was measured with a World Precision Instrument, ISO-NO meter, equipped with a data 
acquisition system, and based on direct amperometric detection of NO with short response time (< 5 s) 
and sensitivity range 1 nM – 20 µM. The analog signal was digitalized with a four-channel recording 
system and transferred to a PC. The sensor was accurately calibrated by mixing standard solutions of 
NaNO2 with 0.1 M H2SO4 and 0.1 M KI according to the reaction:  
 
4H+ + 2I- + 2NO2- → 2H2O + 2NO + I2 
 
Irradiation was performed in a thermostated quartz cell (1 cm path length, 3 mL capacity) under gentle 
stirring by using the same 405 nm laser sources described above. NO measurements were carried out 
with the electrode positioned outside the light path in order to avoid false NO signal due to 
photoelectric interference on the ISO-NO electrode 
 
 
3. Results and discussion 
 
3.1 Syntheses 
The model compound AN-βCD was synthesized according to the procedure illustrated in Scheme 1 
and briefly described in the following (the full details are reported in the Supporting Information).  
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Scheme 1. Reaction scheme for the synthesis of AN-βCD. 
 
6-monotosyl-βCD was promptly converted to the amino-analogue 1 by exhaustive reduction of the 
intermediate 6-monodeoxy-6-monoazido βCD, according to literature (Jicsinszky and Iványi, 2001). 
The amino group, located on the primary rim of CD scaffold, is a suitable anchoring point for the 
introduction of the anthracene chromophore. As compound 1 is obtained as free base, the coupling 
could be achieved by a nucleophilic substitution in DMF with the commercially available 9-
(chloromethyl)anthracene. This reaction setting was explored, but the conversion rate was not 
satisfactory (~30% formation of compound 2) and N-dialkylated product (CD scaffold containing two 
anthracene moieties) was considerably formed under the tested experimental conditions (~10%). 
Although chromatographic purification of the crude can be attempted, the procedure is time-
consuming, not effective and resulted in low-yield. As efficient alternative for the preparation of 
compound (2) a two-steps one-pot reaction based on imine-reduction, allowing good conversion rate 
and avoiding chromatographic purification, was applied. The addition of silica gel to the reaction 
mixture during the first step was a fundamental requirement for achieving quantitative conversion to 
the imine intermediate 1a. The nano-porous material was effective in removing the water accumulated 
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during the condensation process thus making convenient the coupling reaction. The second step based 
on the mild reducing agent sodium borohydride proceeded quantitatively within expectations. The 
introduction of the permanent charges on the CD scaffolds was achieved by using the alkylating agent, 
glycidyltrimethylammonium chloride, as reaction solvent. This approach has the advantages of 
minimizing the by-products formation and reducing the work-up to simple fractional crystallization 
cycles. 
The model compound βCD-NOPD was synthesized according to the procedure illustrated in Scheme 2 
and briefly described in the following (the full details are reported in the Supporting Information).  
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Scheme 2. Reaction scheme for the synthesis of βCD-NOPD. 
 
The flexible linker, 1,3-diaminopropane, was effectively introduced on the CD scaffold by nucleophilic 
substitution on the 6-monotosyl-βCD. In order to reduce the formation of by-products such as CD 
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dimers (two or more CD units connected through the linker) and 3,6-anhydro derivatives, 1,3-
diaminopropane was used in large excess (reaction solvent) and 6-monotosyl-βCD was added portion-
wise to the warm solvent solution. These precautions ensured that 6-monotosyl-βCD was always acting 
as limiting reagent and promptly converted to 6-monodeoxy-6-mono-(3-aminopropylamino) βCD. The 
large excess of 1,3-diaminopropane in combination with an adequate work-up (evaporation under 
reduced pressure and precipitation with methanol-diisopropyl ether mixture) also maintained 
compound 3 in free base form. This is a strict requirement to successfully accomplish the following 
reaction step as no extra base can be added to the reaction mixture due to the high reactivity of 4-
chloro-1-nitro-2-(trifluoromethyl)benzene towards these species. It is worth to mention that the 
decision of attaching the NOPD moiety to the CD scaffold through a linker, was the result of several 
unsuccessful attempts to directly introduce the chromophore on the CD rim. No adequate reaction 
conditions were found to react the reagent 4-chloro-1-nitro-2-(trifluoromethyl)benzene with the free 
base of 6-monoamino-6-monodeoxy-βCD. The most probable reason is that the nitrobenzene derivative 
formed a strong inclusion complex with the βCD cavity locating the chlorine atom on the secondary 
side (Ueno and Breslow, 1982). The establishment of this supramolecular interaction precludes 
primary-side substitution. 
Compound 4 was obtained in moderate yield by reacting the free base of compound 3 with 4-chloro-1-
nitro-2-(trifluoromethyl)benzene. As no extra base could be added to the reaction mixture without 
consuming the chromophore, the product was formed only at around 40% conversion rate. Reversed-
phase chromatographic purification was needed to separate the unreacted compound 3 from the target 
product. The solubility profile of compound 4 was improved by modifying some of the hydroxyl 
groups with permanently charged side-chains. 
The multifunctional conjugate AN-βCD-NOPD was synthesized according to the procedure illustrated 
in Scheme 3 and briefly described in the following (the full details are reported in the Supporting 
Information). In order to introduce both the chromophores on the primary side of the CD scaffold, 
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tosylation of 6-monoazido-6-monodeoxy-βCD was performed in pyridine. This approach is selective 
for the modification of the primary rim of the macrocycle (Matsui et al., 1976) and generates a mixture 
of three pairs of pseudoenantiomers (6A-monodeoxy-6A-monoazido-6X-monotosyl-β-CD, compound 5). 
The mixture of primary-side hetero-disubstituted βCD was isolated by preparative reversed-phase 
chromatography. The strategy developed for the introduction of the NOPD chromophore in model 
compound βCD-NOPD was applied at this stage almost without modifications. The azido moiety 
remained unaltered both in harsh alkaline conditions (preparation of compound 6) and during the 
prolonged heating required for the nitrobenzene installation (preparation of compound 7). The most 
challenging part of the synthetic work was the introduction of the anthracene fluorophore on the 
NOPD-appended CD. A three-step one-pot reaction was carefully designed to fulfill all the necessary 
requirements. First, a mild reduction method was chosen for the selective reduction of azido group in 
the presence of the aromatic nitro group. This approach was based on the use of 1,3-propanedithiol and 
trimethylamine as reduction mixture to obtain the amino-intermediate 7a. Addition of anthracene-9-
carboxaldehyde and heating of the reaction mixture resulted in almost complete conversion (90% 
conversion rate based on TLC estimation) to anthracene-appended imine-intermediate 7b. Portion-wise 
addition of NaBH4 and prolonged stirring at room temperature afforded anthracene-appended amine-
intermediate, compound 8, in quantitative conversion. Preparative reversed-phase chromatographic 
purification allowed the removal of the unreacted compound 7a and the isolation of targeted compound 
8. As the CD scaffold is modified simultaneously with two aromatic units, its solubility in aqueous 
environment is limited. This drawback was overcome by introducing quaternary ammonium bearing 
moieties in the system, obtaining the desired compound AN-βCD-NOPD. 
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Scheme 3. Reaction scheme for the synthesis of AN-βCD-NOPD. 
 
3.2 Spectroscopic properties and photochemical behavior 
All compounds synthesized are well soluble in aqueous medium due to the presence of the cationic 
termination mainly located at the secondary rim of the βCD scaffold. The absorption spectrum of AN-
βCD-NOPD (a in Fig. 1A) exhibits the distinctive spectral features of the anthracene chromophore 
below 400 nm and an intense absorption at longer wavelengths extending beyond 450 nm, due to the 
contribution of the nitroaniline moiety. This spectrum reflects quite well the sum absorption spectrum 
of the independent model compound AN-βCD and βCD-NOPD (b and c in Fig. 2A,), ruling out any 
significant interaction between the anthracene and nitroaniline chromophores in the ground state. On 
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the other hand, the intense fluorescence emission of the anthracene fluorophore observed in the case of 
AN-βCD (d in Fig. 2) is significantly quenched in the bichromophoric conjugate AN-βCD-NOPD (e in 
Fig. 2B), suggesting a remarkable interaction between the two chromophores in the excited state. 
According to what already demonstrated in our previous studies (Vittorino et al., 2011; Kirejev et al., 
2014), this drastic fluorescence quenching can be explained on the basis of a photoinduced energy 
transfer between the anthracene fluorophore and the nitroaniline components in the conjugate, which is 
encouraged by the close proximity of the donor and acceptor, both linked at the same rim. 
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Fig 2. (A) Absorption spectra of 40 µM aqueous solution AN-βCD-NOPD (a) and the model 
compounds AN-βCD (b) and βCD-NOPD (c). (B) Fluorescence emission spectra (λexc = 370 nm) of 
the model compound AN-βCD (d) and AN-βCD-NOPD (e). 
 
The capability of AN-βCD-NOPD to deliver NO under light stimuli was investigated by the direct and 
real-time monitoring of this transient species using an ultrasensitive NO electrode which directly 
reveals NO with nM concentration sensitivity by an amperometric technique (Coneski and 
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Schoenfisch, 2012). The absorption spectral features of AN-βCD-NOPD allow the selective excitation 
of the NO photoreleaser component of the conjugate at λexc > 400 nm. The results illustrated in Figure 
3 provide unambiguous evidence that the bichromophoric CD conjugate is very is stable in the dark but 
supplies NO upon illumination with λexc = 405 nm. Note that, the rate of photorelease is very similar to 
that observed for an optically matched solution of the model compound βCD-NOPD.  
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Fig 3. NO release profile observed for optically matched aqueous solutions of AN-βCD-NOPD (a) and 
βCD-NOPD (b) upon irradiation with λexc = 405 nm at 25 °C. 
 
NO photorelease from AN-βCD-NOPD is accompanied by dramatic revival of the characteristic 
emission arising from the anthracene fluorophore. Fig. 4A shows the fluorescence emission spectra 
observed at regular irradiation times with visible light up to 45 min. This fluorescence restoring is due 
to the formation of a reaction product formed after the loss of NO that, in contrast to the nitroaniline 
derivative, is not a good energy acceptor and thus is not able to quench the fluorescence of the 
anthracene fluorophore. This behavior also reflects in the dynamic of the emission. As shown in the 
inset in Fig. 4A, the fluorescence decay of AN-βCD-NOPD (trace a) was shorter than that of the model 
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compound AN-βCD (trace b). However, after 45 min irradiation of the AN-βCD-NOPD solution, the 
fluorescence dynamic become slower (trace c), according to the revival of the fluorescence. In such a 
way, the anthracene unit represents an excellent optical reporter for the NO release. In fact, as 
illustrated in Fig. 4B, we found an excellent linear correlation between the concentration of NO 
photogenerated and the increase of the fluorescence intensity of the optical reporter.  
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Fig 4. (A) Fluorescence (λexc = 370 nm) spectral changes observed upon irradiation of an aqueous 
solution of AN-βCD-NOPD (40 µM) at regular irradiation times of 5 min (from bottom to top) with 
visible light (λexc = 405 nm). The inset shows the fluorescence decay and the related multiexponential 
fitting for solutions of AN-βCD-NOPD (a), the model compound AN-βCD (b) and AN-βCD-NOPD 
after 45 min irradiation with visible light (c); λexc = 370 nm; λem = 420 nm. (B) Correlation of the 
fluorescence increase observed in Fig. 4A and the concentration of NO released from the same solution 
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(I and I0 represent the fluorescence intensities at 420 nm after each irradiation time and that of the non-
irradiated solution, respectively). 
 
Note that, the suppression of the quenching of the excited state of anthracene after NO release reflects 
also in the capability of this component to photosensitize the formation of singlet oxygen (1O2), the key 
species in photodynamic therapy of cancer and bacterial diseases (Hasan et al., 2000). This was directly 
demonstrated by direct detection through monitoring of the typical phosphorescence of 1O2 in the near-
IR spectral window (Wilkinson et al., 1993). Figure 5 shows that excitation of AN-βCD-NOPD at λexc 
= 370 nm does not lead to any detectable formation of 1O2, according to effective quenching occurring 
of the anthracene by the nitroaniline component.  On the other hand, excitation at the same wavelength 
after irradiating the AN-βCD-NOPD solution for 1 h at 405 nm, leads to the appearance of the 
characteristic luminescence signals of 1O2 with maximum at ca. 1270 (Fig. 5). 
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Fig 5. Luminescence spectra detected upon 370 nm light excitation of a D2O solutions of AN-βCD-
NOPD (40 µM) before () and after () 1 h irradiation at λexc = 405 nm.  
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Despite the covalent linking with the two chromophores, the CD cavity of AN-βCD-NOPD is still able 
to accommodate hydrophobic guests. This was proven by using naphthalene as a model compound, 
which is insoluble in water medium. To this end, a methanol solution of naphthalene was prepared. 
After drying the solvent, the resulting dried sample was added of an aqueous solution of AN-βCD-
NOPD and the sample was stirred for 1 h at room temperature. The mixture was then filtered and 
analysed by UV-Vis absorption. Fig. 6 shows the spectroscopic properties of AN-βCD-NOPD before 
the addition to the film sample (a) and after the filtration procedure (b). The presence of the typical 
structured absorption bands of the naphthalene at ca. 275 and 285 nm (b) provides unambiguous 
evidence for the encapsulation of the guests within the CD cavity. Besides, the characteristic 
fluorescence emission of naphthalene (c in Fig 6) further confirms the effective formation of the host-
guest supramolecular complex. 
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Fig 6. Absorption spectra of an aqueous solution of AN-βCD-NOPD (30 µM) (a) and its complex with 
naphthalene (b) (left Y-axis). Fluorescence emission spectrum (c) observed upon excitation at λexc = 
280 nm of the sample b (right Y-axis). 
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4. Conclusions 
 
We have devised and synthesized a novel multifunctional CD conjugate, bearing a nitroaniline and an 
anthracene chromophoric unit, able to incorporate a number of functionalities within the same 
molecular skeleton. AN-βCD-NOPD is well soluble in water due to the cationic appendages present at 
the lower rim of the CD scaffold and is able to deliver NO under the exclusive control of visible light 
stimuli. NO photorelease restores the fluorescence of the anthracene fluorophore, which acts as an 
optical reporter of NO concentration. To the best of our knowledge, this represents the first example of 
NO photodispenser with fluorescence reporting integrated in a CD scaffold. Furthermore, we have 
demonstrated that the anthracene component is also capable to photogenerate 1O2 sequentially to the 
NO release. The AN-βCD-NOPD conjugate is also able to accommodate hydrophobic guests within 
the βCD cavity, as proven by using naphthalene as a model compound. In view of the key role NO and 
1O2 plays in photodynamic therapy, this βCD derivative represents an intriguing candidate for 
biopharmaceutical research. Studies in this direction are currently underway in our laboratories. 
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